Eton Pharmaceuticals (ETON) Amortizatization of Intangibles (2020 - 2025)
Eton Pharmaceuticals (ETON) posted Amortizatization of Intangibles of $175000.0 for Q4 2025, down 7.41% sequentially from $189000.0 in Q3 2025, and down 83.16% YoY from $1.0 million in Q4 2024.
Eton Pharmaceuticals (ETON) Amortizatization of Intangibles (2020 - 2025) Analysis & Trends
Eton Pharmaceuticals has reported Amortizatization of Intangibles for 6 years, with the latest figure at $175000.0 in Q4 2025.
- Quarterly Amortizatization of Intangibles fell 83.16% year-over-year to $175000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $706000.0 (down 36.74% YoY) and the FY2025 annual result came in at $696000.0, down 37.24% from the prior year.
- Amortizatization of Intangibles eased to $175000.0 in Q4 2025 per ETON's latest filing, from $189000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.0 million in Q4 2024 and troughed at $23000.0 in Q2 2024.
- A 5-year average of $113700.0 and a median of $36000.0 in 2021 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles jumped 3748.15% in 2024, then sank 83.16% in 2025.
- Over 5 years, Amortizatization of Intangibles stood at $38000.0 in 2021, then slipped by 18.42% to $31000.0 in 2022, then decreased by 12.9% to $27000.0 in 2023, then surged by 3748.15% to $1.0 million in 2024, then slumped by 83.16% to $175000.0 in 2025.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $175000.0, $189000.0, and $48000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.67 Bn | 1.65 Bn | 25.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 175,000.00 |
| Dec 31, 2025 | 175,000.00 |
| Sep 30, 2025 | 189,000.00 |
| Sep 30, 2025 | 189,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Mar 31, 2025 | 294,000.00 |
| Mar 31, 2025 | 294,000.00 |
| Dec 31, 2024 | 1.04 Mn |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 29,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | 27,000.00 |
| Dec 31, 2023 | 27,000.00 |
| Sep 30, 2023 | 29,000.00 |
| Sep 30, 2023 | 29,000.00 |